Trial intelligence / Profile preview

Entacapone for methamphetamine-induced effects

NCT02058966Phase 1Completed

Sponsor
Oregon Health & Science University
Start
Jun 2014
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of entacapone in methamphetamine use disorder (MUD), sponsored by Oregon Health & Science University. Started Jun 2014; status: completed.

02

Drugs

entacapone
03

Conditions

methamphetamine use disorder (MUD)

Beyond the preview

Go deeper on NCT02058966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02058966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call